HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
HPS1
HPS1 biogenesis of lysosomal organelles complex 3 subunit 1
Chromosome 10 Β· 10q24.2
NCBI Gene: 3257Ensembl: ENSG00000107521.21HGNC: HGNC:5163UniProt: A0A0S2Z3U9
59PubMed Papers
21Diseases
0Drugs
194Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
guanyl-nucleotide exchange factor activityprotein bindingprotein dimerization activitymelanosome assemblyHermansky-Pudlak syndromeHermansky-Pudlak syndrome with pulmonary fibrosisoculocutaneous albinismpulmonary fibrosis
✦AI Summary

HPS1 encodes a component of the BLOC-3 (biogenesis of lysosome-related organelles complex-3), functioning as a guanine exchange factor (GEF) for RAB32 and RAB38 proteins to promote melanosome biogenesis and melanin production 1. The BLOC-3 complex regulates the conversion of these RAB proteins from inactive GDP-bound to active GTP-bound forms, essential for proper melanosome assembly and membrane localization 1. Mutations in HPS1 cause Hermansky-Pudlak syndrome type 1 (HPS-1), an autosomal recessive disorder characterized by oculocutaneous albinism and platelet storage pool disorder affecting all patients 2. HPS-1 patients additionally develop progressive fibrosing interstitial lung disease and bleeding diathesis, with pulmonary fibrosis representing the leading cause of mortality 3. HPS-1 accounts for approximately 1.6% of oculocutaneous albinism cases in Chinese populations 4. Disease modeling demonstrates that HPS1 mutations cause accumulation of extracellular matrix in lung tissue, suggesting early-onset intractable pulmonary fibrosis 5. Recent evidence identifies age-dependent emergence of inflammatory SAA3+ fibroblasts in HPS1 lungs, with increased IL-1R1 expression indicating complex epithelial-fibroblast interactions driving fibrotic progression 6. Currently, lung transplantation remains the only definitive therapeutic option for HPS-1 pulmonary fibrosis 7.

Sources cited
1
HPS1 is a component of BLOC-3 complex functioning as a GEF for RAB32 and RAB38, promoting GDP to GTP exchange and melanosome biogenesis
PMID: 23084991
2
HPS-1 is an autosomal recessive disorder with albinism, bleeding diathesis, and pulmonary fibrosis associated with BLOC-3 deficiency; approximately 333 Puerto Rican HPS subjects reported
PMID: 31898847
3
HPS-1 presents with oculocutaneous albinism, platelet storage pool disorder, progressive fibrosing interstitial lung disease, and bleeding diathesis; pulmonary fibrosis is the leading cause of mortality
PMID: 41110930
4
HPS1 mutations account for 1.6% of oculocutaneous albinism cases in Chinese patients
PMID: 19865097
5
HPS1 mutations in lung organoid models cause extracellular matrix accumulation and suggest early-onset intractable pulmonary fibrosis
PMID: 28436965
6
HPS1 lungs show age-dependent increase in inflammatory SAA3+ fibroblasts with increased IL-1R1 expression, indicating epithelial-fibroblast interactions in fibrotic progression
PMID: 39987372
7
HPS-1 pulmonary fibrosis lacks definitive therapeutic approaches other than lung transplantation
PMID: 27514596
Disease Associationsβ“˜21
Hermansky-Pudlak syndromeOpen Targets
0.82Strong
Hermansky-Pudlak syndrome with pulmonary fibrosisOpen Targets
0.71Strong
oculocutaneous albinismOpen Targets
0.47Moderate
pulmonary fibrosisOpen Targets
0.47Moderate
inflammatory bowel diseaseOpen Targets
0.47Moderate
Abnormal bleedingOpen Targets
0.46Moderate
genetic disorderOpen Targets
0.42Moderate
lung diseaseOpen Targets
0.37Weak
pulmonary vascular congestionOpen Targets
0.30Weak
benign prostatic hyperplasiaOpen Targets
0.26Weak
facial morphologyOpen Targets
0.15Weak
type 2 diabetes mellitusOpen Targets
0.15Weak
ureterolithiasisOpen Targets
0.08Suggestive
Griscelli diseaseOpen Targets
0.08Suggestive
Abruptio PlacentaeOpen Targets
0.08Suggestive
Tietz syndromeOpen Targets
0.07Suggestive
Griscelli disease type 3Open Targets
0.07Suggestive
Griscelli syndrome type 3Open Targets
0.07Suggestive
bone neoplasmOpen Targets
0.07Suggestive
oculocutaneous albinism type 3Open Targets
0.07Suggestive
Hermansky-Pudlak syndrome 1UniProt
Pathogenic Variants194
NM_000195.5(HPS1):c.1472_1487dup (p.His497fs)Pathogenic
Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome|not provided|Inborn genetic diseases|HPS1-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 497
NM_000195.5(HPS1):c.769-14_834delLikely pathogenic
not provided|Hermansky-Pudlak syndrome 1
β˜…β˜…β˜†β˜†2026
NM_000195.5(HPS1):c.1925del (p.Gly642fs)Pathogenic
not provided|Hermansky-Pudlak syndrome 1|HPS1-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 642
NM_000195.5(HPS1):c.398+5G>APathogenic
Hermansky-Pudlak syndrome 1|not provided|Hermansky-Pudlak syndrome
β˜…β˜…β˜†β˜†2026
NM_000195.5(HPS1):c.1198del (p.Asp400fs)Pathogenic
Hermansky-Pudlak syndrome 1|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 400
NM_000195.5(HPS1):c.1189del (p.Gln397fs)Pathogenic
Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome|not provided|HPS1-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 397
NM_000195.5(HPS1):c.355del (p.His119fs)Pathogenic
Hermansky-Pudlak syndrome 1|not provided|Hermansky-Pudlak syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 119
NM_000195.5(HPS1):c.1744-2A>CPathogenic
Hermansky-Pudlak syndrome|not provided|Hermansky-Pudlak syndrome 1
β˜…β˜…β˜†β˜†2025
NM_000195.5(HPS1):c.391C>T (p.Arg131Ter)Pathogenic
not provided|Hermansky-Pudlak syndrome|Hermansky-Pudlak syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 131
NM_000195.5(HPS1):c.962dup (p.Thr322fs)Pathogenic
Hermansky-Pudlak syndrome 1|not provided|Hermansky-Pudlak syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 322
NM_000195.5(HPS1):c.1858-1G>APathogenic
Hermansky-Pudlak syndrome|not provided|Hermansky-Pudlak syndrome 1
β˜…β˜…β˜†β˜†2025
NM_000195.5(HPS1):c.988-1G>TPathogenic
not provided|Hermansky-Pudlak syndrome|Hermansky-Pudlak syndrome 1
β˜…β˜…β˜†β˜†2025
NM_000195.5(HPS1):c.962del (p.Gly321fs)Pathogenic
Hermansky-Pudlak syndrome|not provided|Hermansky-Pudlak syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 321
NM_000195.5(HPS1):c.972del (p.Met325fs)Pathogenic
Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome|not provided|HPS1-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 325
NM_000195.5(HPS1):c.467_476del (p.Tyr156fs)Pathogenic
not provided|Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 156
NM_000195.5(HPS1):c.868-1G>CLikely pathogenic
not provided|Hermansky-Pudlak syndrome
β˜…β˜…β˜†β˜†2025
NM_000195.5(HPS1):c.716T>C (p.Leu239Pro)Pathogenic
not provided|Hermansky-Pudlak syndrome|Hermansky-Pudlak syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 239
NM_000195.5(HPS1):c.2003T>C (p.Leu668Pro)Pathogenic
not provided|Hermansky-Pudlak syndrome|Hermansky-Pudlak syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 668
NM_000195.5(HPS1):c.517C>T (p.Arg173Ter)Pathogenic
not provided|Hermansky-Pudlak syndrome|Hermansky-Pudlak syndrome 1
β˜…β˜…β˜†β˜†2025β†’ Residue 173
NM_000195.5(HPS1):c.50G>A (p.Trp17Ter)Pathogenic
not provided|Hermansky-Pudlak syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 17
View on ClinVar β†—
Related Genes
BLOC1S6Protein interaction99%BLOC1S3Protein interaction99%DTNBP1Protein interaction98%BLOC1S5Protein interaction88%SNAPINProtein interaction88%BLOC1S2Protein interaction87%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
79%
Liver
66%
Ovary
60%
Heart
38%
Brain
23%
Gene Interaction Network
Click a node to explore
HPS1BLOC1S6BLOC1S3DTNBP1BLOC1S5SNAPINBLOC1S2
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q92902
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.88LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.70 [0.56–0.88]
RankingsWhere HPS1 stands among ~20K protein-coding genes
  • #7,779of 20,598
    Most Researched59
  • #361of 5,498
    Most Pathogenic Variants194 Β· top 10%
  • #7,806of 17,882
    Most Constrained (LOEUF)0.88
Genes detectedHPS1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Hermansky-Pudlak syndrome: Mutation update.
PMID: 31898847
Hum Mutat Β· 2020
1.00
2
A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism.
PMID: 19865097
J Invest Dermatol Β· 2010
0.90
3
PMID: 20301464
0.80
4
A three-dimensional model of human lung development and disease from pluripotent stem cells.
PMID: 28436965
Nat Cell Biol Β· 2017
0.70
5
Hermansky-Pudlak Syndrome.
PMID: 41110930
Clin Chest Med Β· 2025
0.60